KZR (Kezar Life Sciences, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Kezar Life Sciences, Inc. Common Stock (KZR) is a publicly traded Healthcare sector company. As of May 21, 2026, KZR trades at $7.29 with a market cap of $53.86M and a P/E ratio of -0.95. KZR moved -0.82% today. Year to date, KZR is +14.80%; over the trailing twelve months it is +76.94%. Its 52-week range spans $3.53 to $9.18. Analyst consensus is neutral with an average price target of $7.00. Rallies surfaces KZR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns KZR stock?
Hedge funds tracked by Rallies that own KZR include Panagora Asset and Orbimed Advisors. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Kezar Life Sciences, Inc. Common Stock.
KZR Key Metrics
Key financial metrics for KZR
Metric
Value
Price
$7.29
Market Cap
$53.86M
P/E Ratio
-0.95
EPS
$-7.66
Dividend Yield
0.00%
52-Week High
$9.18
52-Week Low
$3.53
Volume
0
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-56.03M
Gross Margin
0.00%
Top Hedge Funds Holding KZR
Panagora Asset holds 233.21K shares of KZR, changed +177.34% as of Mar 31, 2024.
Orbimed Advisors holds 192.70K shares of KZR, changed +0.00% as of Sep 30, 2025.
Hedge funds tracked by Rallies that own KZR include Panagora Asset and Orbimed Advisors. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Kezar Life Sciences, Inc. Common Stock.
Does Rallies show 13F holders for KZR?
Yes. Rallies tracks hedge fund and 13F ownership data for KZR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is KZR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for KZR. It does not provide personalized investment advice.
